Phase 1/2 AAV5-hRKp.RPGR (Botaretigene Sparoparvovec) Gene Therapy: Safety and Efficacy in RPGR-Associated X-Linked Retinitis Pigmentosa

MICHAELIDES, MICHEL, BESIRLI, CAGRI G., YANG, YESA · American Journal of Ophthalmology · 2024